. 2023 Oct 29;18:100303. doi: 10.1016/j.lansea.2023.100303

Table 2.

Estimated coverage^a with the first and second dose of measles-containing vaccine (MCV), vaccination schedule,^b number of reported measles cases,^c and measles incidence,^d^,^e by country — World Health Organization South-East Asia Region, 2003 and 2022.

Country	2003						2022						% change, 2003–2022
	WHO/UNICEF estimated coverage^a (%)		MCV schedule^b		No. reported measles cases (JRF)^c	measles incidence^d^,^e	WHO/UNICEF estimated coverage^a (%)		MCV schedule^b		No. reported measles cases (JRF)^c	Measles incidence^d^,^e	MCV1 coverage	measles incidence^e
	MCV1	MCV2	MCV1	MCV2	No. reported measles cases (JRF)^c	measles incidence^d^,^e	MCV1	MCV2	MCV1	MCV2	No. reported measles cases (JRF)^c	Measles incidence^d^,^e	MCV1 coverage	measles incidence^e
Bangladesh	76	—^f	M-9 m	—^f	4067	30.2	97	93	MR-9 m	MR-15 m	311	1.8	28	−94
Bhutan	88	—^f	M-9 m	—^f	0	0.0	97	97	MMR-9 m	MMR-24 m	7^j	0	10	0
DPR Korea	95	—^f	M-9 m	—^f	0	0.0	0^k	0^k	MR-9 m	MR-15 m	0	0	−100	0
India	60	—^f	M-9 m	—^f	47,147	42.4	95	90	MR-9 m	MR-16–24 m	40,967	28.9	58	−32
Indonesia	74	21^g	M-9 m	M-7 y^g	24,457	111.0	84	67	MR-9 m	MR-18 m^h	7704	28	14	−75
Maldives	96	—^f	M-9 m	—^f	75	247.8	98	98	MR-9 m	MMR-18 m	0	0	2	−100
Myanmar	80	—^f	M-9 m	—^f	830	17.2	75	90	MR-9 m	MR-18 m	10	0.2	−6	−99
Nepal	75	—^f	M-9 m	—^f	13,344	532.0	90	87	MR-9 m	MR-15 m	130	4.3	20	−99
Sri Lanka	99	90	M-9–12 mⁱ	MR-3 y	65	3.4	99	98	MMR-9 m	MMR-3 y	0	0.0	0	−100
Thailand	96	92	M-9 m	MMR-6 y	4519	70.0	96	87	MMR-9 m	MMR-1.5 y	64	0.9	0	−99
Timor-Leste	55	—^f	M-9 m	—^f	94	99.2	79	78	MR-9 m	MR-18 m	8^j	0	44	−94
Region overall	66	6			94,598	57.4	92	85			49,201	23.8	39	−59

JRF = joint reporting form; m = months; M = measles; MCV = measles-containing vaccine; MR = measles-rubella; MMR = measles-mumps-rubella; UNICEF = United Nations Children’s Fund; y = years.

Data were from WHO and UNICEF estimates, 2020 revision (as of July 2021). Data available at http://immunizationdata.who.int.

As reported to WHO/UNICEF on JRFs for the year.

JRF was submitted to WHO and UNICEF by member states with the official immunization data and the number of measles cases in the country for the year.

Measles incidence is calculated based on the reported measles cases and population by member states through WHO/UNICEF JRF.

Cases per million population (excluding imported cases in countries verified to have eliminated measles).

MCV2 was not introduced into routine immunization.

Sub-national introduction in schools of West Java at age 7 years.

MCV third dose given in schools at grade 1.

ⁱ

Changed in 2011 from age 9 months to 9–12 months.

Imported or import related cases.

No vaccination conducted due to COVID-19 pandemic related barriers leading to vaccine stockout.